Skip to content

Opening book details…

Can I read Long-term follow-up of autologous stem cell transplantation in patients with diffuse mantle cell lymphoma in first disease remission: The prognostic value of ?2-microglobulin and the tumor score on EtoBox?

Long-term follow-up of autologous stem cell transplantation in patients with diffuse mantle cell lymphoma in first disease remission: The prognostic value of ?2-microglobulin and the tumor score by Issa F. Khouri; Rima M. Saliba; Grace-Julia Okoroji; Sandra A. Acholonu; Richard E. Champlin is a Medicine article available to read on EtoBox.

What is Long-term follow-up of autologous stem cell transplantation in patients with diffuse mantle cell lymphoma in first disease remission: The prognostic value of ?2-microglobulin and the tumor score about?

BACKGROUND. The current study was conducted to analyze the long-term results of autologous stem cell transplantation (ASCT) in patients with diffuse mantle cell lymphoma (MCL) in first disease remission. METHODS. Thirty-three patients were treated. Thirty-one patients had Ann Arbor Stage III or Stage IV disease. The hyper-CVAD regimen (hyperfractionated intensedose cyclophosphamide, vincristine, continuous intravenous infusion of doxorubicin, and dexamethasone, alternating with high doses of cytarabine and methotrexate plus leucovorin rescue) was used for cytoreduction before ASCT. Patients were consolidated with high-dose cyclophosphamide (120 mg/kg), total body irradiation, and ASCT. ## RESULTS. At a median follow-up of 49 months, the overall survival and diseasefree-survival rates at 5 years were estimated to be 77% and 43%, respectively. Patients whose M. D. Anderson Lymphoma Tumor Score (TS) was Յ 1 at the time of diagnosis or transplantation experienced longer disease-free survival compared with those whose TS was Ͼ 1 (P ϭ 0.02). A ␤ 2 -microglobulin (␤ 2 m)level Յ 3 mg/L at the time of diagnosis or transplantation was also found to be strongly predictive of longer survival (

Who reads Long-term follow-up of autologous stem cell transplantation in patients with diffuse mantle cell lymphoma in first disease remission: The prognostic value of ?2-microglobulin and the tumor score?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Issa F. Khouri; Rima M. Saliba; Grace-Julia Okoroji; Sandra A. Acholonu; Richard E. Champlin
Publisher
John Wiley and Sons; Wiley (John Wiley & Sons); John Wiley & Sons Inc.; Wiley (ISSN 0008-543X)
Published
2003
Language
EN
Field
Medicine (Health Sciences)

More by Issa F. Khouri; Rima M. Saliba; Grace-Julia Okoroji; Sandra A. Acholonu; Richard E. Champlin

Browse all works by Issa F. Khouri; Rima M. Saliba; Grace-Julia Okoroji; Sandra A. Acholonu; Richard E. Champlin